Pharmacophore modeling using site-identification by ligand competitive saturation (SILCS) with multiple probe molecules.
Ontology highlight
ABSTRACT: Receptor-based pharmacophore modeling is an efficient computer-aided drug design technique that uses the structure of the target protein to identify novel leads. However, most methods consider protein flexibility and desolvation effects in a very approximate way, which may limit their use in practice. The Site-Identification by Ligand Competitive Saturation (SILCS) assisted pharmacophore modeling protocol (SILCS-Pharm) was introduced recently to address these issues, as SILCS naturally takes both protein flexibility and desolvation effects into account by using full molecular dynamics simulations to determine 3D maps of the functional group-affinity patterns on a target receptor. In the present work, the SILCS-Pharm protocol is extended to use a wider range of probe molecules including ben
SUBMITTER: Yu W
PROVIDER: S-EPMC4339487 | biostudies-literature | 2015 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA